BACTIFLOX 500MG TAB

each lactab contains 582.2 mg ciprofloxacin hydrochloride equivalent to 500 mg ciprofloxacin.

31.00 EGP

Purchase this product now and earn 31 Points!

BACTIFLOX 500MG TAB; cephalosporins, antibacterials .

ACTIVE-INGREDIENT OF BACTIFLOX 500MG TAB

each lactab contains 582.2 mg ciprofloxacin hydrochloride equivalent to 500 mg ciprofloxacin.

INDICATION OF BACTIFLOX 500MG TAB

bactiflox lactabs are indicated for the treatment of the following infections , special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy . Consideration should be given to official guidance on the appropriate use of antibacterial agents . adults : lower respiratory tract infections due to gram-negative bacteria – exacerbations of chronic obstructive pulmonary disease – broncho-pulmonary infections in cystic fibrosis or in bronchoiectasis – pneumonia – chronic suppurative otitis media . – acute exacerbation of chronic sinusitis especially if these are caused by gram -negative bacteria to urinary tract infections . gonococcal urethritis and cervicitis .epididmyo- orchitis including cases due to neisseria gonorrhoeae . pelvic inflammatory disease including cases due to neisseria gonorrhoeae in the above genital tract infections when throught or known to be due to neisseria gonorrhoeae it is particulary important obtained local information on the prevalence of resistance to ciprofloxacin and to confirm susceptibility based on laboratory testing . – infections of the gastrointestinal tract (e.g) travellers’ diarrhoea ) . intra-abdominal infections . infections of the skin and soft tissue caused by gram -negative bacteria . malignant external otitis . infections of the bones and joints . – treatment of infections in neutropenic patients .- prophylaxis of infection in neutropenic patients .prophylaxis of invasive infections due to neisseria meningitidis . – inhalation anthrax ( post-exposure prophylaxis and curative treatment ) children and adolescents . broncho-pulmonary infections in cystic fibrosis caused by pseudomonas aeruginosa . complicated urinary tract infections and pyelonephritis . inhalation anthrax ( post-exposure prophylaxis and curative treatment ) ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary . treatment should be initiated only by the physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents .

DOSAGE OF BACTIFLOX 500MG TAB

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

The dosage is determined by the indication, the severity and the site of the infection, the susciptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight. The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course. Treatment of infections due to certain bacteria (e.g. Pseudomonas aeruginosa, Acinetobacter or Stapyloocci) may require higher ciprofloxacin doses and co-administration with other appropriate antibacterial agents. Treatment of some infections (e.g.pelvic inflammatory disease, intra-abdominal infections, infections in neutropenic patients and infections of bones and joints) may require co-administration with other appropriate antibacterial agents depending on the pathogens involved. Adults: In case of infections of lower respiratory tract : Daily dose in mg : 500 mg twice daily to 750 mg twice daily. Total duration of treatment : 7 to 14 days. In case of infections of the upper respiratory tract ( Acute exacerbation of chronic sinusitis) : Daily dose in mg : 500 mg twice daily to 750 mg twice daily. Total duration of treatment : 7 to 14 days. in case of infections of the upper respiratory tract ( chronic suppurative otitis media ) : Daily dose in mg : 500 mg twice daily to 750 mg twice daily. Total duration of treatment : 7 to 14 days. in case of infections of the upper respiratory tract (Malignant external otitis) : Daily dose in mg : 750 mg twice daily. Total duration of treatment : 28 days up to 3 months. In case of Urinary tract infections ( Uncomplicated cystitis) : Daily dose in mg : 250 mg twice daily to 500 mg twice daily. Total duration of treatment : 3 days. In case of Urinary tract infections ( complicated cystitis, Uncomplicated pyelonephiritis ) : Daily dose in mg : 500 mg twice daily. Total duration of treatment :7 days. In case of Urinary tract infections ( complicated pyelonephiritis ) : Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment :at least 10 days, it can be continued for longer than 21 days in some specific circumstances (such as abscesses). In case of Urinary tract infections ( Prostatitis ) : Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment :2 to 4 weeks(acute) to 4 to 6 weeks (chronic). In case of genital tract infections( Gonococcal uretritis and cervicitis) : Daily dose in mg : 500 mg as a single dose. Total duration of treatment : 1 day (single dose). In case of genital tract infections( .epididmyo- orchitis and pelvic inflammatory diseases) : Daily dose in mg : 500 mg twice daily to 750 mg twice daily. Total duration of treatment : at least 14 days. In case of infections of the gastrointestinal tract and intra-abdominal infections: ( diarrhoea caused by pathogens including Shigella spp. Other than Shigella dysenteriae type 1 And empirical treatment of severe travellers’ diarrhoea): Daily dose in mg : 500 mg twice daily . Total duration of treatment : 1 day. In case of infections of the gastrointestinal tract and intra-abdominal infections: ( diarrhoea caused by Shigella dysenteriae type 1): Daily dose in mg : 500 mg twice daily . Total duration of treatment : 5 days . In case of infections of the gastrointestinal tract and intra-abdominal infections: ( diarrhoea caused by Vibrio cholerae): Daily dose in mg : 500 mg twice daily . Total duration of treatment : 3 days . In case of infections of the gastrointestinal tract and intra-abdominal infections: ( Typhoid fever ): Daily dose in mg : 500 mg twice daily . Total duration of treatment : 7 days . In case of infections of the gastrointestinal tract and intra-abdominal infections: ( intra-abdominal infections due to Gram-negative bacteria ): Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment : 5 to 14 days . In case of infections of the skin and soft tissue: Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment : 7 to 14 days . In case of bone and joint infections : Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment :max. of 3 months. In case of treatment of infections or prophylaxis of infections in neutropenic patients : Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment : therapy should be continued over the entire peroid of neutropenia. Ciprofloxacin should be co-administered with appropriate antibacterial agent(s) in accordance to official guidance. In case of inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to recieve treatment by oral route when clinically appropriate. Drug administration should begin as soon as possible after suspected or confirmed exposure: Daily dose in mg : 500 mg twice daily . Total duration of treatment : 60 days from the confirmation of Bacillus anthracis exposure). In case of infections of the gastrointestinal tract and intra-abdominal infections: ( diarrhoea caused by Shigella dysenteriae type 1): Daily dose in mg : 500 mg twice daily . Total du ration of treatment : 5 days . In case of infections of the gastrointestinal tract and intra-abdominal infections: ( diarrhoea caused by Vibrio cholerae): Daily dose in mg : 500 mg twice daily . Total duration of treatment : 3 days . In case of infections of the gastrointestinal tract and intra-abdominal infections: ( Typhoid fever ): Daily dose in mg : 500 mg twice daily . Total duration of treatment : 7 days . In case of infections of the gastrointestinal tract and intra-abdominal infections: ( intra-abdominal infections due to Gram-negative bacteria ): Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment : 5 to 14 days . In case of infections of the skin and soft tissue: Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment : 7 to 14 days . In case of bone and joint infections : Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment :max. of 3 months. In case of treatment of infections or prophylaxis of infections in neutropenic patients : Daily dose in mg : 500 mg twice daily to 750 mg twice daily . Total duration of treatment : therapy should be continued over the entire peroid of neutropenia. Ciprofloxacin should be co-administered with appropriate antibacterial agent(s) in accordance to official guidance. In case of inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to recieve treatment by oral route when clinically appropriate. Drug administration should begin as soon as possible after suspected or confirmed exposure: Daily dose in mg : 500 mg twice daily . Total duration of treatment : 60 days from the confirmation of Bacillus anthracis exposure).Children and adolescents: Bactiflox is used in children and adolescents, under specialist medical supervision, to treat the following bacterial infections: Lung and bronchial infections in children and adolescents suffering from cystic fibrosis. Complic ated urinary tract infections, including infections that have reached the kidneys (pylonephritis). Anthrax inhalation exposure Bactiflox may also be used to treat other specific severe infections in children and adolescents when your doctor considered this necessary. Geriatric patients should recieve a dose selected according to the severity of the infection and the patient’s creatinine clearance. Renal and hepatic impairment Recommended starting and maintenance doses for patients with impaired renal function: Creatinine clearance: in case of ( > 60 ml/min , serum creatinine <124 µ mol/L): Oral dose : See usual dosage. in case of (30-60 ml/min , serum creatinine 124-168 µ mol/L): Oral dose : 250-500 mg every 12 h. in case of (< 30 ml/min , serum creatinine > 169 µ mol/L): Oral dose : 250-500 mg every 24 h. In case of Patients on haemodialysis , serum creatinine > 169 µ mol/L: Oral dose : 250-500 mg every 24 h( after dialysis). in case of Patients on peritomeal dialysis Serum creatinine > 169 µ mol/L): Oral dose : 250-500 mg every 24 h . In patients with impaired liver function no dose adjustment is required. Dosing in children with impaired renal and/or hepatic function has not been studied. Method of administration Tablets are to swallowed unchewed with fluid. They can be taken independent of mealtimes. If taken on an empty stomach, the active substance is absorbed more rapidly. Bactiflox lactabs should not be taken with dairy products (e.g. milk, yoghurt) or miniral-fortified fruit-juice ( e.g. calcium-fortified orange juice) . In severe cases or if patient is unable to take tablets (e.g. patients on enteral nutrition), it is recommended to commance therapy with intravenous ciprofloxacin until as switch to oral administration is possible.

OVER-DOSAGE OF BACTIFLOX 500MG TAB

an overdose of 12 g has been reported to lead to mild symptoms of toxicity . An acute overdose of 16 g has been reported to cause acute renal failure . Symptoms of overdose consist of dizziness , tremor , headache tiredness , seizures , hallucinations , confusion , abdominal discomfort , renal and hepatic impairment as well as crysalluria and haematuria reversible renal toxcicity has been reported . apart from routine emergency measures , it is recommended to monitor renal function , including urinary ph and acidify , if required , to prevent crystalluria . patients should be kept well hydrated . only a small quantity of cipreofloxcin (<10%) is eliminated by haemodialysis or peritoneal dialysis .

CONTRA-INDICATION OF BACTIFLOX 500MG TAB

hypersensitivity to the active substance, to other quinolones or to any of the excipients . Concomitant administration of ciprofloxacin and tizanidine .

STORAGE OF BACTIFLOX 500MG TAB

PACK OF BACTIFLOX 500MG TAB
CARTON BOX containing on AL/PVC strip of 10 lactabs + inner leaflet .
BACTIFLOX 500MG TAB MANUFACTURED BY
MEDICAL UNION PHARMACEUTICALS .

https://www.drugs.com/drug-class/cephalosporins.html

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

1 review for BACTIFLOX 500MG TAB

  1. abdo (verified owner)

    very nice

Add a review

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top